Context Therapeutics Inc.
Context Therapeutics Inc. (CNTX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CNTX · as of Jun 9, 2026
Activity summary
Buy transactions
3
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Context Therapeutics Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
CNTX insider buying and selling by quarter
CNTX insider selling · CNTX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
CNTX executive sell shares · CNTX board member insider trading · CNTX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 9, 2025 | Lehr Martin A. CEO · Director | Purchase | 100,000 | $70K | Form 4 |
| Jun 6, 2025 | Levit Alex C. Chief Legal Officer, Corp. Sec | Purchase | 20,000 | $12K | Form 4 |
| Jun 6, 2025 | Minai-Azary Jennifer Lynn CFO | Purchase | 40,010 | $25K | Form 4 |
| Feb 21, 2023 | Lehr Martin A. CEO · Director | Purchase | 5,823 | $5K | Form 4 |
| Feb 13, 2023 | Lehr Martin A. CEO · Director | Purchase | 5,606 | $5K | Form 4 |
| Feb 6, 2023 | Lehr Martin A. CEO · Director | Purchase | 5,040 | $5K | Form 4 |
| Jan 30, 2023 | Lehr Martin A. CEO | Purchase | 7,027 | $5K | Form 4 |
| Jan 23, 2023 | Lehr Martin A. CEO | Purchase | 6,839 | $5K | Form 4 |
| Jan 17, 2023 | Lehr Martin A. CEO | Purchase | 6,783 | $5K | Form 4 |
| Dec 16, 2022 | Minai-Azary Jennifer Lynn CFO | Purchase | 25,000 | $19K | Form 4 |
| Dec 16, 2022 | Lehr Martin A. CEO | Purchase | 20,000 | $15K | Form 4 |
| Dec 9, 2022 | Levit Alex C. Chief Legal Officer, Corp. Sec | Purchase | 6,000 | $5K | Form 4 |
| Aug 19, 2022 | Lehr Martin A. CEO | Purchase | 13,000 | $24K | Form 4 |
| Aug 17, 2022 | Minai-Azary Jennifer Lynn CFO | Purchase | 15,000 | $27K | Form 4 |
| Aug 16, 2022 | Sahmoud Tarek Chief Medical Officer | Purchase | 10,000 | $20K | Form 4 |
| Dec 16, 2021 | Lehr Martin A. CEO · Director | Purchase | 13,000 | $42K | Form 4 |
| Oct 22, 2021 | Levit Alex C. Chief Legal Officer, Corp. Sec | Purchase | 3,000 | $15K | Form 4 |
| Oct 22, 2021 | Lehr Martin A. CEO · Director | Other | 586,476 | — | Form 4 |
| Oct 22, 2021 | Lehr Martin A. CEO · Director | Other | 210,722 | — | Form 4 |
| Oct 22, 2021 | Lehr Martin A. CEO · Director | Purchase | 10,000 | $50K | Form 4 |
| Oct 22, 2021 | Lehr Martin A. CEO · Director | Other | 52,680 | $376K | Form 4 |
| Oct 22, 2021 | Dick Evan G. SVP of R&D | Other | 26,587 | — | Form 4 |
Levit Alex C.
Chief Legal Officer, Corp. Sec
Date
Jun 6
Shares
20,000
Price
$0.58
Value
$12K
Levit Alex C.
Chief Legal Officer, Corp. Sec
Date
Dec 9
Shares
6,000
Price
$0.85
Value
$5K
Sahmoud Tarek
Chief Medical Officer
Date
Aug 16
Shares
10,000
Price
$1.95
Value
$20K
Levit Alex C.
Chief Legal Officer, Corp. Sec
Date
Oct 22
Shares
3,000
Price
$5.00
Value
$15K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CNTX insider trading
CNTX insider trades
Context Therapeutics Inc. (CNTX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including CNTX. Over the past 12 months, 0 insiders have filed transactions with the SEC. CNTX insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Context Therapeutics Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CNTX insider trading · 5 questionsThe insiders of Context Therapeutics Inc. (CNTX) include executives and directors such as CNTX, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026